Questcor (QCOR) Up on Positive Insurer Backing
Tweet Send to a FriendGet Alerts QCOR Hot Sheet
Price: $35.29 -2%
Overall Analyst Rating:
NEUTRAL (= Flat)
Dividend Yield: 2.9%
Revenue Growth %: +40.7%
Overall Analyst Rating:
NEUTRAL (= Flat)
Dividend Yield: 2.9%
Revenue Growth %: +40.7%
Trade QCOR Now!
Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) is tracking slightly higher Wednesday after Wellpoint told Bloomberg that Acthar is considered medically necessary for infantile spasms and there has been no change in coverage over the past year.
The news comes amid recent issues with insurer willingness to pay for the drug.
Shares of QCOR last traded at $26.08, up 0.6%.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The news comes amid recent issues with insurer willingness to pay for the drug.
Shares of QCOR last traded at $26.08, up 0.6%.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Crash in American Electric Power (AEP) & NextEra Energy (NEE) Adds to Jitters
- Dry Bulkers on Watch as Diana Shipping (DSX) Swings to Q1 Loss (DRYS) (FREE)
- Fusion-io (FIO) Valuation, Technology Might Attract Buyers
Create E-mail Alert Related Categories
Trader Talk
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
